IN2GEN Co., Ltd.
Records under this name other than patents IN2GEN Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to IN2GEN Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,041,635 | Factor VIII polypeptide Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,407,958 | 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors Formerly held Term ended Term ended Nov 9, 2025 · USPTO record | Term ended | Term ended Nov 9, 2025 | USPTO record |
| US 7,495,022 | α,β-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors Formerly held Lapsed on the fee record Ended Feb 24, 2021 · USPTO record | Lapsed on the fee record | Ended Feb 24, 2021 | USPTO record |
| US 6,962,911 | Pyrrolopyrimidinone derivatives, process of preparation and use Formerly held Term ended Term ended Feb 15, 2021 · USPTO record | Term ended | Term ended Feb 15, 2021 | USPTO record |